Efficacy of Adaptogens in Patients With Long COVID-19

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

November 11, 2021

Study Completion Date

December 26, 2021

Conditions
Covid19
Interventions
DIETARY_SUPPLEMENT

ADAPT-232 oral solution

"One ml of ADAPT 232/CHISAN oral solution contains:~Fructus Schizandrae native extract DERnative 2-4:1, (extraction solvent . 95% ethanol) - 10 mg corresponding to 20-40 mg dried fruit; Radix Eleutherococci native extract DERnative 17-30:1 (extraction solvent - 70% ethanol) - 2.6 mg corresponding to 44-78 mg dried rhizomes, and Radix Rhodiolae native extract DERnative 2-5:1 (extraction solvent - 70% ethanol) - 3 mg corresponding to 6-30 mg dried rhizomes.~Excipients"

OTHER

Placebo oral solution

Excipients

Trial Locations (1)

0102

National Family Medicine Training Centre,, Tbilisi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Family Medicine Training Centre, Georgia

UNKNOWN

collaborator

Tbilisi State Medical University

OTHER

collaborator

Phytomed AB

OTHER

lead

Swedish Herbal Institute AB

INDUSTRY